Skip to main content
AKBA
NASDAQ Life Sciences

Akebia Refinances BlackRock Debt With Up to $140M Symbiotic Term Loan

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.474
Mkt Cap
$131.668M
52W Low
$0.361
52W High
$1.835
52W Position info
31% above low
Off High info
74% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

AKBA sits 31% above its 52-week low of $0.361.

Summary

Akebia closed a senior secured term loan with Symbiotic Capital on November 12: a $60M initial tranche was fully funded and used to repay its $55M BlackRock facility in full, with up to $80M more available at Symbiotic's discretion. The loan runs 60 months, is interest-only for the full term with principal due at maturity, and carries a variable rate of the greater of WSJ Prime plus 4.5% or 11.5%. Management reaffirmed its cash runway guidance of at least two years, which matters given the Q3 10-Q warning that Vafseo revenue is expected to drop significantly in 2027 when TDAPA ends. This is non-dilutive capital that pushes out the BlackRock maturity and removes near-term refinancing pressure, though the 11.5% floor is an expensive cost of capital for a company with a $14.4M quarterly net loss. The 8-K with full loan terms is expected today.

At the time of this announcement, AKBA was trading at $0.47 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $131.7M. The 52-week trading range was $0.36 to $1.84. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

AKBA - Latest Insights

AKBA
Nov 05, 2026, 7:37 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $0.5199
Real-time Price: $0.4821 info
Change: -$0.0378 (-7%) info
Market Cap: $131.668M info
AKBA
Nov 05, 2026, 7:10 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $0.69337
Real-time Price: $0.4821 info
Change: -$0.21127 (-30%) info
Market Cap: $131.668M info
AKBA
Nov 05, 2026, 7:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.69337
Real-time Price: $0.4821 info
Change: -$0.21127 (-30%) info
Market Cap: $131.668M info
AKBA
Oct 26, 2026, 9:20 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.5765
Real-time Price: $0.4821 info
Change: -$0.0944 (-16%) info
Market Cap: $131.668M info
AKBA
Oct 23, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.5745
Real-time Price: $0.4821 info
Change: -$0.0924 (-16%) info
Market Cap: $131.668M info